---
title: Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
description: How Quality Research Initiatives are Advancing Precision Oncology and Value-Based Care
---

# Newsroom

For Press Contact

[media@integraconnect.com](mailto:media@integraconnect.com)

Announcements

[In The News](https://insights.integraconnect.com/news?type=in-the-news) [Thought Leadership](https://insights.integraconnect.com/news?type=thought-leadership)

[

Back

](https://insights.integraconnect.com/news?type=in-the-news)

### Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy

Jul 25, 2023

Life Sciences

Click here to [read the original article at SAMPLE WEBSITE.](https://blogsite.healtheconomics.com/2023/05/how-quality-research-initiatives-are-advancing-precision-oncology-and-value-based-care/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect",
    "url" : "https://insights.integraconnect.com/news/author/integra-connect"
  },
  "dateModified" : "2023-07-27T20:02:14.435Z",
  "datePublished" : "2023-07-25T19:40:00.000Z",
  "headline" : "Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy",
  "mainEntityOfPage" : {
    "@id" : "https://insights.integraconnect.com/news/initiating-treatment-after-molecular-testing-may-improve-outcomes-for-advanced-nsclc-0",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://insights.integraconnect.com/hubfs/IntegraConnect%20/ic-logo-text-dark-gray.png"
    },
    "name" : "Integra Connect"
  }
}
```